![]() |
Volumn 106, Issue 5, 2008, Pages 1588-
|
Which hemostatic changes determine clinical outcome?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR 7;
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 9;
FIBRIN;
FIBRINOGEN;
GELATIN;
VON WILLEBRAND FACTOR;
COAGULATING AGENT;
HETASTARCH;
ISOTONIC SOLUTION;
PLASMA SUBSTITUTE;
RINGER'S LACTATE;
BLEEDING;
BLOOD CLOTTING;
BLOOD CLOTTING DISORDER;
COLLOID;
HEMODILUTION;
HUMAN;
LETTER;
OUTCOME ASSESSMENT;
PEROPERATIVE CARE;
POLYMERIZATION;
PRIORITY JOURNAL;
THROMBOCYTE ADHESION;
THROMBOCYTE FUNCTION;
BLOOD CLOTTING TEST;
BLOOD TRANSFUSION;
DRUG EFFECT;
HEMOSTASIS;
NOTE;
ORTHOPEDIC SURGERY;
THROMBOELASTOGRAPHY;
TREATMENT OUTCOME;
BLOOD COAGULATION TESTS;
BLOOD LOSS, SURGICAL;
BLOOD TRANSFUSION;
COAGULANTS;
FIBRINOGEN;
GELATIN;
HEMODILUTION;
HEMOSTASIS;
HETASTARCH;
HUMANS;
ISOTONIC SOLUTIONS;
ORTHOPEDIC PROCEDURES;
PLASMA SUBSTITUTES;
THROMBELASTOGRAPHY;
TREATMENT OUTCOME;
|
EID: 42449103498
PISSN: 00032999
EISSN: None
Source Type: Journal
DOI: 10.1213/ane.0b013e31816a31fc Document Type: Letter |
Times cited : (2)
|
References (2)
|